Do 5HT-3 receptor antagonists ameliorate cholestatic pruritus?
Porcel, J.M.; Vives, M.; Cano, M.; Rubio-Caballero, M.
Anales de Medicina Interna 12(8): 411
1995
ISSN/ISBN: 0212-7199 PMID: 8924539 Document Number: 450959
Document emailed within 1 workday
Related Documents
Sapey, T. 1998: Opiod antagonists and treatment of cholestatic pruritus Gastroenterologie Clinique et Biologique 22(2): 255-256King, G.L.; Rabin, B.M.; Weatherspoon, J.K. 1999: 5-HT3 receptor antagonists ameliorate emesis in the ferret evoked by neutron or proton radiation Aviation Space and Environmental Medicine 70(5): 485-492
Balak, D.M.W.; Hajdarbegovic, E. 2019: More on Mu-Opioid Receptor Antagonists in PD-1 Blockade–Induced Pruritus New England Journal of Medicine 380(6): 601
Moreno, J.A. 1975: Use of phenobarbital in the management of pruritus associated with cholestatic jaundice of pregnancy Ginecologia y Obstetricia de Mexico 37(222): 213-217
Nielsen, S.T.; Dove, P.A.; Strike, D.P.; Schiehser, G.A. 1987: Structural modification of H2-receptor antagonists provide post-H2-receptor gastric antisecretory activity Drugs under Experimental and Clinical Research 13(5): 297-304
Daniels, A.J.; Matthews, J.E.; Viveros, O.H.; Leban, J.J.; Cory, M.; Heyer, D. 1995: Structure-activity relationship of novel pentapeptide neuropeptide y receptor antagonists is consistent with a noncontinuous epitope for ligand-receptor binding Molecular Pharmacology 48(3): 425-432
Desai, M.A.; Burnett, J.P.; Ornstein, P.L.; Schoepp, D.D. 1995: Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists Journal of Pharmacology and Experimental Therapeutics 272(1): 38-43
Berbis, P. 1996: Pruritus (with the exception of anal and vulvar pruritus). Diagnostic orientation La Revue du Praticien 46(11): 1423-1426
Bonnetblanc, J.M.; Sparsa, A. 2000: Pruritus (other than anal and vulvar pruritus). Diagnostic orientation La Revue du Praticien 50(2): 183-188
Saller, C.F.; Czupryna, M.J.; Salama, A.I. 1990: 5-HT2 receptor blockade by ICi 169,369 and other 5-HT2 antagonists modulates the effects of D-2 dopamine receptor blockade Journal of Pharmacology and Experimental Therapeutics 253(3): 1162-1170
Pellas, T.C.; Wennogle, L.P. 1999: C5a receptor antagonists Current Pharmaceutical Design 5(10): 737-755
Mazure, P.A. 1996: Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA) Acta Gastroenterologica Latinoamericana 26(4): 263-265
Sewing, K.F. 1976: Histamine H2-receptor antagonists Acta Hepato-Gastroenterologica 23(3): 221-226
Chung, O.; Unger, T. 1996: Angiotensin Ii receptor antagonists Der Internist 37(5): 534-538; Discussion 538
Domschke, S.; Domschke, W. 1980: New histamine H2-receptor antagonists Hepato-Gastroenterology 27(3): 163-168
Perez, E.A. 1996: Use of dexamethasone with 5-HT3-receptor antagonists Oncology 10(1): 14
Boeynaems, J.-M.; van Giezen, H.; Savi, P.; Herbert, J.-M. 2005: P2Y receptor antagonists in thrombosis Current Opinion in Investigational Drugs 6(3): 275-282
Perez, E.A. 1996: Use of dexamethasone with 5-HT3-receptor antagonists Oncology 10(1): 14
Spitz, I.M. 2006: Progesterone receptor antagonists Current Opinion in Investigational Drugs 7(10): 882-890
Bornkessel, B. 1995: Angiotensin Ii receptor antagonists Medizinische Monatsschrift für Pharmazeuten 18(6): 148-151